Avid Bioservices Inc (CDMO)

[jessme]

Makes much more sense than the Peregrine CEO line "We're in talks."


To get the deal-making juices flowing, the company has been sharing the new ANA598 data under confidentiality agreements.

What I think we can say is that on the basis of that data, and being able to share it under confidentiality with companies, we were able to expand the group of companies committed to a full due diligence process around [ANA]598," said Anadys CEO

In a note to clients last week, JMP Securities analyst Liisa Bayko said nine potential partners/acquirers for Anadys were in the hunt:
Schering-Plough
Merck(
Boeringher Ingelheim,
Bristol-Myer Squibb(
Gilead Sciences
Novartis
Johnson & Johnson
Vertex
Pfizer


"We believe that management is executing an M&A [mergers and acquisitions] process engineering to bring all serious contenders to the table simultaneously to maximize shareholder value," said Bayko. She has a market outperform rating on Anadys, but her firm has no banking relationship with the company.

http://www.thestreet.com/_yahoo/story/10482738/1/anadys-tries-to-tempt-suitors-with-hep-c-data.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA